genprowebdirectory

GEN Edge
News
Insights
- Trends for 2020
A-Lists
Topics
Magazine
- Supplement
Resources
- Posters
- Videos
- Webinars
- eBooks
- Podcasts
- Events
- New Products
- Tutorial
- Best of the Web
- Best Apps
Subscribe

Search

Advertising
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In

GEN – Genetic Engineering and Biotechnology News

Mary Ann Liebert, Inc. Publishers

GEN Edge
- Antibody Drug Conjugates
  
  AbCellera’s CEO: Flattening the Curve of Technology Development
  
  Cancer
  
  After Final Medicare LCD from Palmetto GBA, OncoCyte Pursues Private Coverage…
  
  Coronavirus
  
  COVID-19 Puts Spotlight on Artificial Intelligence
  
  Data Management
  
  VAST Ambition When It Comes To Data Storage
  
  Antisense
  
  NeuBase Sets a Course for the Clinic
News
- Cancer
  
  Cancer Immunotherapy Study Identifies New Checkpoint Targets in Myeloid Cells
  
  Translational Medicine
  
  p53’s Multiple Roles Are Acquired during Pluripotent Stem Cell Differentiation
  
  Drug Discovery
  
  Ketamine’s Antidepressant Activity Examined at Brain Receptor Level
  
  Coronavirus
  
  SARS-CoV-2 Likely Entered New York City from European and U.S. Sources
  
  Infectious Diseases
  
  New Recombineering Method May Overcome Key Obstacle in Genetically Engineering Bacteria
Insights
- All Trends for 2020
  
  Bioprocessing
  
  COVID-19 Will Have Long Lasting Impact on Biopharma Manufacturing
  
  Bioprocessing
  
  Decreasing the Time from Antibody Idea to IND Approval
  
  Bioprocessing
  
  Introducing New Bioprocessing Technologies in the Era of COVID-19
  
  Bioprocessing
  
  Smart AI Use Could Benefit Biopharma
A-Lists
- Coronavirus
  
  Blinking Red: 25 Missed Pandemic Warning Signs
  
  Coronavirus
  
  Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
  
  Coronavirus
  
  Catching Up to Coronavirus: Top 60 Treatments in Development
  
  Drug Discovery
  
  Top 15 Best-Selling Drugs of 2019
  
  Coronavirus
  
  How to Conquer Coronavirus: Top 35 Treatments in Development
Topics
- All Bioprocessing Cancer Drug Discovery OMICs Translational Medicine Genome Editing
  
  Cancer
  
  Cancer Immunotherapy Study Identifies New Checkpoint Targets in Myeloid Cells
  
  Translational Medicine
  
  p53’s Multiple Roles Are Acquired during Pluripotent Stem Cell Differentiation
  
  Upcoming Webinars
  
  Kicking Up an Immune System Storm: COVID-19 and Hyper-Inflammation
  
  Drug Discovery
  
  Ketamine’s Antidepressant Activity Examined at Brain Receptor Level
Magazine
- All Supplement
  
  Coronavirus
  
  Race for a Coronavirus Vaccine
  
  Drug Discovery
  
  Protein Modulation Helps Drug Design Get a Grip
  
  OMICs
  
  Proteomic Mass Spec Assesses Biomolecular Teamwork
  
  Coronavirus
  
  COVID-19 Drives CRISPR Diagnostics
Resources
- All Posters Videos Webinars eBooks Podcasts Events New Products Tutorial Best of the Web Best Apps
  
  Upcoming Webinars
  
  Kicking Up an Immune System Storm: COVID-19 and Hyper-Inflammation
  
  On Demand Webinars
  
  Organoids and Spheroids Help Science See in 3D
  
  Upcoming Webinars
  
  A CRISPR Vision for the Future of Cell Therapy
  
  Upcoming Webinars
  
  Looking toward the Future of Cell & Gene Therapies
Subscribe

Home Therapeutics Vaccines

Vaccines

Exploring Novel Vaccine Characterization Methodologies

Vaccines

Type 1 Diabetes Risk Lower in Infants with Rotavirus Vaccination

Vaccines

Vaccine Storage and Transport Transformed with Sugary Gel

Vaccines

Merck to Acquire Immune Design for $300M, Boosting Immunotherapy Vaccine Pipeline

Vaccines

Recurrent Tonsillitis Insights Might Lead to Strep Vaccine

Vaccines

Tumor Microenvironments Are Target-Rich Environments

Vaccines

Hospitalized Patients Can Safely Receive Flu Vaccine

Vaccines

Adaptable Vaccine Strategy For Emerging Flaviviruses

Vaccines

Cancer Vaccines: Using Neo-Antigen Peptide Array Screening

Vaccines

Cancer Vaccine Kills Cancer Cells and the Cells They Dupe

Vaccines

Norovirus Insights May Improve Conditions Below Deck

Vaccines

Moderna Files for Largest-Ever Biotech IPO, Seeking to Raise $500M

Vaccines

Immunocompromised Patients Could Get Help from New Vaccine Strategy

GEN Edge

AbCellera’s CEO: Flattening the Curve of Technology Development

After Final Medicare LCD from Palmetto GBA, OncoCyte Pursues Private Coverage for NSCLC Stratification Test

COVID-19 Puts Spotlight on Artificial Intelligence

VAST Ambition When It Comes To Data Storage

NeuBase Sets a Course for the Clinic

All GEN Edge Stories

Recently Featured

Cocaine Cravings Curbed Dramatically in Mice Treated Using New Small Molecule

On PAR: How X and Y Chromosomes Recombine During Meiosis

Electrogenetic Device Allows Remote Control of Cell Signaling

Brain Tumor Immune Microenvironment Profiled

Phase III Trial to Study Combination of Genentech’s Actemra, Gilead’s Remdesivir vs. Severe COVID-19

Explore

About GEN
Contact GEN
GEN Staff
Editorial Guidelines
Press Releases
Reprints and Permissions
2020 Planning Calendar
Scientific Advisory Board

Advertise

GEN Media Kit
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
List Rental
Advertising Terms and Conditions

Resources

Get the GEN Magazine
Get the GEN Email Newsletter
New Products
Videos
Webinars
Podcasts
Privacy Policy
Clinical OMICs

Home
Terms of Service
Privacy Policy
Cookie Policy
Mary Ann Liebert, Inc.

Scroll Up

×

Please wait while you are redirected to the right page...

We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our privacy policy.

Edit with Live CSS

Save

Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.